Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
Coelho Mary Theresa 0001103021-20-000019.pdf 0001103021-20-000019.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0001103021-20-000020.pdf 0001103021-20-000020.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Cukier Herm 0001103021-20-000021.pdf 0001103021-20-000021.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Vollins James 0001103021-20-000022.pdf 0001103021-20-000022.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0001103021-20-000012.pdf 0001103021-20-000012.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Coelho Mary Theresa 0001103021-20-000010.pdf 0001103021-20-000010.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-20-000008.pdf 0001103021-20-000008.rtf 0001103021-20-000008.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0001103021-20-000006.pdf 0001103021-20-000006.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0001103021-20-000004.pdf 0001103021-20-000004.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-20-000002.pdf 0001103021-20-000002.rtf View HTML

Data provided by Kaleidoscope.

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon